Published in Eur J Immunol on November 01, 2008
CD207+ CD103+ dermal dendritic cells cross-present keratinocyte-derived antigens irrespective of the presence of Langerhans cells. J Exp Med (2009) 2.75
Individual cell movement, asymmetric colony expansion, rho-associated kinase, and E-cadherin impact the clonogenicity of human embryonic stem cells. Biophys J (2010) 1.21
TLR2-dependent modulation of dendritic cells by LT-IIa-B5, a novel mucosal adjuvant derived from a type II heat-labile enterotoxin. J Leukoc Biol (2011) 0.87
Characterization of mononuclear phagocytic cells in medaka fish transgenic for a cxcr3a:gfp reporter. Proc Natl Acad Sci U S A (2010) 0.86
Differences in T-helper polarizing capability between human monocyte-derived dendritic cells and monocyte-derived Langerhans'-like cells. Immunology (2010) 0.83
Cytokines and chemokines in irritant contact dermatitis. Mediators Inflamm (2013) 0.80
Regulation of Dendritic Cell Function in Inflammation. J Immunol Res (2015) 0.79
Inflammatory conditions distinctively alter immunological functions of Langerhans-like cells and dendritic cells in vitro. Immunology (2015) 0.77
Viruses exploit the tissue physiology of the host to spread in vivo. Curr Opin Cell Biol (2016) 0.75
Topical pimecrolimus inhibits high-dose UVB irradiation-induced epidermal Langerhans cell migration, via regulation of TNF-α and E-cadherin. Drug Des Devel Ther (2014) 0.75
Chemokine Receptor Ccr7 Restricts Fatal West Nile Virus Encephalitis. J Virol (2017) 0.75
Ontogeny and function of murine epidermal Langerhans cells. Nat Immunol (2017) 0.75
Near-Infrared 1064 nm Laser Modulates Migratory Dendritic Cells To Augment the Immune Response to Intradermal Influenza Vaccine. J Immunol (2017) 0.75
Loss of MAPK-activated protein kinase 2 enables potent dendritic cell-driven anti-tumour T cell response. Sci Rep (2017) 0.75
CCR7 coordinates the primary immune response by establishing functional microenvironments in secondary lymphoid organs. Cell (1999) 12.50
Murine epidermal Langerhans cells mature into potent immunostimulatory dendritic cells in vitro. J Exp Med (1985) 11.14
Langerhans cells renew in the skin throughout life under steady-state conditions. Nat Immunol (2002) 7.03
Dynamics and function of Langerhans cells in vivo: dermal dendritic cells colonize lymph node areas distinct from slower migrating Langerhans cells. Immunity (2005) 6.48
Mice lacking expression of secondary lymphoid organ chemokine have defects in lymphocyte homing and dendritic cell localization. J Exp Med (1999) 6.09
The plasticity of dendritic cell responses to pathogens and their components. Science (2001) 5.58
CCR7 governs skin dendritic cell migration under inflammatory and steady-state conditions. Immunity (2004) 5.48
Epidermal viral immunity induced by CD8alpha+ dendritic cells but not by Langerhans cells. Science (2003) 5.00
Regulation of dendritic cell migration to the draining lymph node: impact on T lymphocyte traffic and priming. J Exp Med (2003) 4.64
Dendritic-cell trafficking to lymph nodes through lymphatic vessels. Nat Rev Immunol (2005) 4.59
Rapid and coordinated switch in chemokine receptor expression during dendritic cell maturation. Eur J Immunol (1998) 4.51
Identification of a novel population of Langerin+ dendritic cells. J Exp Med (2007) 4.13
Epidermal langerhans cell-deficient mice develop enhanced contact hypersensitivity. Immunity (2005) 4.06
Vaginal submucosal dendritic cells, but not Langerhans cells, induce protective Th1 responses to herpes simplex virus-2. J Exp Med (2003) 3.86
Inducible ablation of mouse Langerhans cells diminishes but fails to abrogate contact hypersensitivity. J Cell Biol (2005) 3.75
Depletion of host Langerhans cells before transplantation of donor alloreactive T cells prevents skin graft-versus-host disease. Nat Med (2004) 3.17
CCR7 is critically important for migration of dendritic cells in intestinal lamina propria to mesenteric lymph nodes. J Immunol (2006) 3.04
The leukotriene C(4) transporter MRP1 regulates CCL19 (MIP-3beta, ELC)-dependent mobilization of dendritic cells to lymph nodes. Cell (2000) 2.76
Differential regulation of chemokine receptors during dendritic cell maturation: a model for their trafficking properties. J Immunol (1998) 2.70
Langerhans cells are not required for efficient skin graft rejection. J Invest Dermatol (2008) 2.41
Modulation of dendritic cell trafficking to and from the airways. J Immunol (2006) 2.17
Autocrine/paracrine TGFbeta1 is required for the development of epidermal Langerhans cells. J Exp Med (2007) 2.00
Controls for lung dendritic cell maturation and migration during respiratory viral infection. J Immunol (2007) 1.83
Insights into Langerhans cell function from Langerhans cell ablation models. Eur J Immunol (2008) 1.65
CXCL12-CXCR4 engagement is required for migration of cutaneous dendritic cells. Am J Pathol (2007) 1.64
Langerhans cells are required for efficient presentation of topically applied hapten to T cells. J Immunol (2007) 1.61
Langerin expressing cells promote skin immune responses under defined conditions. J Immunol (2008) 1.54
UV exposure reduces immunization rates and promotes tolerance to epicutaneous antigens in humans: relationship to dose, CD1a-DR+ epidermal macrophage induction, and Langerhans cell depletion. Proc Natl Acad Sci U S A (1992) 1.52
Matrix metalloproteinases 9 and 2 are necessary for the migration of Langerhans cells and dermal dendritic cells from human and murine skin. J Immunol (2002) 1.49
CCL19/CCL21-triggered signal transduction and migration of dendritic cells requires prostaglandin E2. Blood (2003) 1.46
Expression of gp40, the murine homologue of human epithelial cell adhesion molecule (Ep-CAM), by murine dendritic cells. Eur J Immunol (1996) 1.44
PGE2-induced metalloproteinase-9 is essential for dendritic cell migration. Blood (2007) 1.38
Stromal cell-derived factor-1alpha promotes melanoma cell invasion across basement membranes involving stimulation of membrane-type 1 matrix metalloproteinase and Rho GTPase activities. Cancer Res (2004) 1.38
Epidermal and dermal dendritic cells display differential activation and migratory behavior while sharing the ability to stimulate CD4+ T cell proliferation in vivo. J Immunol (2008) 1.34
Alpha 6 integrins are required for Langerhans cell migration from the epidermis. J Exp Med (1997) 1.32
Tumor immunotherapy by epicutaneous immunization requires langerhans cells. J Immunol (2008) 1.31
CXCL12 is essential for migration of activated Langerhans cells from epidermis to dermis. Eur J Immunol (2008) 1.15
CXCR4 engagement promotes dendritic cell survival and maturation. Biochem Biophys Res Commun (2007) 1.04
Langerhans cells and viral immunity. Eur J Immunol (2008) 1.03
Both Langerhans cells and interstitial DC cross-present melanoma antigens and efficiently activate antigen-specific CTL. Eur J Immunol (2007) 1.01
IFN-gamma enables cross-presentation of exogenous protein antigen in human Langerhans cells by potentiating maturation. Proc Natl Acad Sci U S A (2004) 1.00
Fourteenth Annual Pezcoller Symposium: the novel dichotomy of immune interactions with tumors. Cancer Res (2003) 0.97
Selected natural and synthetic retinoids impair CCR7- and CXCR4-dependent cell migration in vitro and in vivo. J Leukoc Biol (2008) 0.89
Solar-simulated ultraviolet radiation induces abnormal maturation and defective chemotaxis of dendritic cells. J Invest Dermatol (2005) 0.86
Dendritic cell migration and lymphocyte homing imprinting. Histol Histopathol (2008) 0.85
Mast cell degranulation upregulates alpha 6 integrins on epidermal Langerhans cells. J Invest Dermatol (1993) 0.83
Characteristics and functions of murine cutaneous dendritic cells: a synopsis of recent developments. Mucosal Immunol (2008) 0.82